| Tue, Sep 29, 2009 | | • | The Medicines Company Licenses Innovative New Formulation of Argatroban; Gains Strategic Complement to Angiomax Franchise and Potential Near Term Revenue Opportunity
Marketwire (Tue, Sep 29)
| | Fri, Sep 25, 2009 | | • | Angiomax Reduced Cardiac Mortality by 41%; Reduced Overall Mortality by 25% in Severe Heart Attack Patients Following Angioplasty
Marketwire (Fri, Sep 25)
| | Wed, Sep 23, 2009 | | • | 4 Stocks Losing Top Investor Support
at Motley Fool (Wed, Sep 23)
| | Wed, Sep 16, 2009 | | • | The Medicines Company to Participate in the UBS Global Life Sciences Conference
Marketwire (Wed, Sep 16)
| | Tue, Sep 15, 2009 | | • | The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635
Marketwire (Tue, Sep 15)
| | Fri, Sep 4, 2009 | | • | The Medicines Company Receives Paragraph IV Notifications
Marketwire (Fri, Sep 4)
| | Wed, Sep 2, 2009 | | • | The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635
Marketwire (Wed, Sep 2)
| | • | The Medicines Company Announces New Patent Issuance for Angiomax(R)
Marketwire (Wed, Sep 2)
| | Mon, Aug 31, 2009 | | • | The Medicines Company Announces New Publication of Data Showing Angiomax(R) Reduces Cardiac Mortality and Improves Overall Survival
Marketwire (Mon, Aug 31)
| | Thu, Aug 20, 2009 | | • | The Medicines Company Withdraws European Marketing Application for 3-7 Day Daily Dose Oritavancin Therapy
Marketwire (Thu, Aug 20)
| | Fri, Aug 14, 2009 | | • | The Medicines Company Announces Option Grants Under Nasdaq Marketplace Rule 5635
Marketwire (Fri, Aug 14)
| | Mon, Aug 10, 2009 | | • | MEDICINES CO /DE Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Aug 10)
| | • | The Medicines Company Responds to Incorrect News Reports
Marketwire (Mon, Aug 10)
| | Fri, Jul 31, 2009 | | • | MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Fri, Jul 31)
| | • | The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635
Marketwire (Fri, Jul 31)
| | Wed, Jul 29, 2009 | | • | MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Wed, Jul 29)
| | • | The Medicines Company Earnings Call scheduled for 8:30 am ET today
CCBN (Wed, Jul 29)
| | • | The Medicines Company Reports Second Quarter 2009 Financial Results
Marketwire (Wed, Jul 29)
| | Mon, Jul 27, 2009 | | • | MEDICINES CO /DE Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Mon, Jul 27)
| | Thu, Jul 23, 2009 | | • | The Medicines Company Appoints T. Scott Johnson as Vice President, New Business Ventures & Chief Medical Advisor
Marketwire (Thu, Jul 23)
| | Wed, Jul 15, 2009 | | • | The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635
Marketwire (Wed, Jul 15)
| | • | The Medicines Company to Announce Second Quarter 2009 Financial Results on Wednesday, July 29, 2009
Marketwire (Wed, Jul 15)
| | Tue, Jun 30, 2009 | | • | The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635
Marketwire (Tue, Jun 30)
| | Fri, Jun 19, 2009 | | • | FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)
Marketwire (Fri, Jun 19)
| | Tue, Jun 16, 2009 | | • | The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635
Marketwire (Tue, Jun 16)
|
Add MDCO News to My Yahoo!:
 
| |
|
0.08% Nasdaq 
0.15%
Headlines
